Table 2.
Pathological results of EUS-TA of SPLs ≤10 mm, n (%).
| Pathological results | n (%) (Total n = 108) |
|---|---|
| Neuroendocrine tumor | 42 (38.9) |
| Pancreatic ductal adenocarcinoma | 15 (13.9) |
| clinical stage IA | 15 (100) |
| Metastatic tumor | 4 (3.7) |
| Lung carcinoma | 1 (25) |
| Colorectal carcinoma | 1 (25) |
| Breast carcinoma | 1 (25) |
| Sarcoma | 1 (25) |
| Intrapancreatic accessory spleen | 4 (3.7) |
| SPN | 3 (2.8) |
| SCN | 2 (1.9) |
| Chronic pancreatitis | 2 (1.9) |
| PEComa | 1 (0.9) |
| No malignancy | 35 (32.4) |
EUS-TA: EUS tissue acquisition; PEComa: Perivascular epithelioid cell tumor; SCN: Serous cystic neoplasm; SPL: Solid pancreatic lesion; SPN: Solid pseudopapillary neoplasm.